Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway

Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway

Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85% of lung cancers. Mitogen-Activated Protein Kinase (MAPK) signaling pathways are a vital aspect of NSCLC, and have a...

Full description

Bibliographic Details
Main Authors: Anisha S. Jain, Ashwini Prasad, Sushma Pradeep, Chandan Dharmashekar, Raghu Ram Achar, Ekaterina Silina, Victor Stupin, Raghavendra G. Amachawadi, Shashanka K. Prasad, R Pruthvish, Asad Syed, Chandan Shivamallu, Shiva Prasad Kollur
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
drug repurposing/repositioning
MAPK
targeted therapy
inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.741326/full

Similar Items

Similar Items